Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole

Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects

(2012) Stephen A. Villano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Mortality Associated with Catabacter hongkongensis Bacteremia

(2012) S. K. P. Lau et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

(2012) J. C. Arthur et al.   SCIENCE

FLASH: fast length adjustment of short reads to improve genome assemblies

(2011) T. Magoc et al.   BIOINFORMATICS

Antibiotics and the resistant microbiome

(2011) Morten OA Sommer et al.   CURRENT OPINION IN MICROBIOLOGY

Probiotics in the gastrointestinal diseases of the elderly

(2011) G. Malaguarnera et al.   Journal of Nutrition Health & Aging

Metagenomic biomarker discovery and explanation

(2011) Nicola Segata et al.   GENOME BIOLOGY

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample

(2010) J. G. Caporaso et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection

(2008) T. J. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile-Associated Disease

(2008) W. N. Al-Nassir et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Skin and Environmental Contamination With Vancomycin-Resistant Enterococci in Patients Receiving Oral Metronidazole or Oral Vancomycin Treatment for Clostridium difficile–Associated Disease

(2008) Ajay K. Sethi et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Effective and Reduced-Cost Modified Selective Medium for Isolation of Clostridium difficile

(2008) M. M. Nerandzic et al.   JOURNAL OF CLINICAL MICROBIOLOGY